Header
Author: Federal Department of Home Affairs (EDI)
Source: news.admin.ch – Press Release
Publication Date: 4 December 2025
Reading Time: 4 minutes
Executive Summary
Starting in 2026, Switzerland is expanding the benefits of compulsory health insurance by adding digital health applications for depression treatment and making transcatheter aortic valve implantation (TAVI) permanently available for low-risk patients aged 75 and over. These decisions are based on evidence of effectiveness and create opportunities for low-threshold therapy access, while implementation deadlines for artificial nutrition are extended by one year – a pragmatic course between innovation and feasibility.
Critical Guiding Questions (liberal-journalistic)
Innovation Responsibility: How does the state ensure quality standards for digital therapy applications without stifling market dynamics?
Access Equality: Will digital therapies truly become more accessible, or will digitalization barriers exacerbate existing inequalities?
Evaluation Transparency: What cost implications and long-term effects formed the basis of these decisions – and are these publicly traceable?
Scenario Analysis: Future Perspectives
Short Term (2026–2027)
- Digital depression therapies are covered by mandatory health insurance (OKP) for the first time nationwide
- Implementation deadline for artificial nutrition is extended by one year
- TAVI benefits expanded for aging low-risk patients
Medium Term (2027–2030)
- Digital therapy offerings establish themselves as standard care; cost development becomes measurable
- Systemic questions arise about digital therapies' role as complement or substitute for psychotherapy
- Long-term data on TAVI outcomes in older patients influence scope and application limits
Long Term (2030+)
- Technological advances expand digital indications (AI-assisted diagnostics)
- Tension between cost containment and care innovation sharpens
- Political debates over E-health opportunities and risks become central to premium dynamics
Main Summary
Core Topic & Context
The Federal Department of Home Affairs updates the Health Care Services Ordinance (KLV) with three focal points: cost coverage for digital depression therapies, stabilization of TAVI service scope, and implementation facilitation for artificial nutrition. These changes enter into force partially in 2026 and partially in 2027, based on evidence-based evaluations and cost-effectiveness reviews.
Key Facts & Figures
- Effective 1 July 2026: Mandatory health insurance covers costs for digital health applications for cognitive behavioral therapy (CBT) in mild to moderate depressive disorders – prescription by specialists required
- Indications: Supplement to psychotherapy or as bridging solution during waiting periods
- Effective 1 January 2026: TAVI coverage obligation is permanently expanded to low-risk patients aged 75 and over (previously limited until 31.12.2025)
- Evaluation Result: TAVI meets criteria of effectiveness, appropriateness, and cost-effectiveness even in expanded indication ⚠️ (evaluation results not disclosed in detail)
- Postponement: Artificial nutrition system moved back one year to 1 January 2027 – organizational and technical implementation hurdles
- Regulatory Deep Structure: Nutrient solutions henceforth in MiGeL, parenteral nutrition in specialist list (SL), non-physician provider services transferred to KLV
- Process Continuity: BAG closely accompanies artificial nutrition transition; further KLV adjustments made in appendices and list systems
Stakeholders & Affected Parties
- Insured Persons: Benefit from low-threshold therapy access (digital), aging cardiac patients (TAVI)
- Medical Service Providers: Psychologists, cardiologists, general practitioners receive new prescription options
- Insurance Companies: Price negotiations with digital therapy software providers necessary; cost implications unclear
- Medical Technology & Pharma: Digital CBT app providers gain OKP access; TAVI manufacturers benefit from broadened indication
- System Responsibility (BAG, Cantons): Must coordinate transition processes
Opportunities
✅ Access Democratization: Digital therapies lower geographic and temporal barriers to depression treatment
✅ Evidence-Based: All decisions supported by randomized studies/evaluations
✅ Age-Appropriate Care: TAVI access for older patients with better prognosis than open surgery
✅ Innovation Signal: OKP positions itself as modern, technology-open
Risks
⚠️ Quality Challenge: No statement on approval standards for digital apps – risk of ineffectiveness or data protection gaps
⚠️ Cost Explosion: ⚠️ Penetration rates and long-term costs of digital therapies not quantified
⚠️ Waiting Time Illusion: Digital apps do not replace psychotherapy; without capacity expansion, queue-shifting threatens
⚠️ Implementation Delay: Artificial nutrition shows that regulatory system changes take time – risk of further postponements
⚠️ TAVI Overtreatment: ⚠️ Low-risk patients could be overtreated if indication strictness declines
Action Relevance
| Stakeholder | Action | Priority |
|---|---|---|
| Insured Persons | Inform about new digital therapy options; clarify individual fit | High |
| Health Insurers | Conclude contracts with app providers; develop cost models | High |
| Service Providers | Training in digital therapy workflows; update prescription protocols | Medium |
| BAG/Regulation | Publish quality criteria catalog for digital apps; increase evaluation result transparency | High |
Quality Assurance & Fact-Checking
✅ Verified:
- Effective dates (1 July 2026 for digital CBT, 1 January 2026 for TAVI, 1 January 2027 for artificial nutrition)
- Legal foundations (KLV, KVG) correctly referenced
- Depression indications (mild to moderate) and prescription requirements confirmed
⚠️ Not Disclosed in Detail / Requires Research:
- Concrete cost implications of new benefits (OKP premium impact)
- TAVI study evaluation results (mortality, morbidity, cost comparison to open surgery)
- Approval/quality criteria for digital CBT apps (BAG standard)
- Implementation progress on artificial nutrition (status May 2025)
Supplementary Research
BAG Press Releases on Digital Therapies (2025):
Search term: "Digital Health Applications OKP"
Relevance: Official approval criteria, conformity with EU DiGA standardsTAVI Evaluation Report (Health Observatory):
Search term: "TAVI Evaluation 2024 Switzerland low-risk patient"
Relevance: Long-term outcomes, cost comparison, age effectsHealth Insurance Statistics BSV/BfS (2024–2025):
Search term: "OKP service expenditures mental health"
Relevance: Context for depression treatment and therapy capacityComparison: E-Health Strategies Switzerland vs. Germany (DiGA Registry):
Relevance: Best practice in digital therapy procedures; transparency standards
Reference List
Primary Source:
Federal Department of Home Affairs (EDI) – Press Release: Digital Therapy Offerings Can Now Be Covered by Health Insurance (4 December 2025)
Ordinance Texts:
Supplementary Sources:
- Federal Office of Public Health (BAG): New OKP Benefits – Overview Page
- Clarus News Topic Cluster: Swiss Health Insurance
- Clarus News Topic Cluster: Swiss Health System
Verification Status: ✅ Facts checked against original announcement on 4 December 2025
🎯 Implication for Executives
Strategic Signals:
- Regulatory: OKP benefit expansion signals willingness to integrate technological innovations – opportunities for digital health companies
- Operational: Insurers and service providers must quickly implement workflows (July 2026 deadline)
- Market-Economical: Digital therapy becomes standard benefit – software providers should prioritize conformity with Swiss approval standards